Reform Biologics, LLC

Calculating rank

USPTO Granted Patents = 5

% Expired Patents = 20.0

CIPO Patents = 13

Forward Citations = 51

Loading Chart...

6 inventors (with patents filed for the assignee):

Robert P Mahoney (5 out of 58 patents)

Philip Wuthrich (5 out of 15 patents)

David S Soane (5 out of 85 patents)

4. Mark Moody (3 out of 9 patents)

5. Daniel G Greene (3 out of 6 patents)

6. Rosa Casado Portilla (3 out of 24 patents)

5 patents: Sort by Forward Citations

1. 10478498 - Excipient compounds for biopolymer formulations (2019-11-19),

2. 10279048 - Stabilizing excipients for therapeutic protein formulations (2019-05-07),

3. 10016513 - Stabilizing excipients for therapeutic protein formulations (2018-07-10),

4. 9867881 - Viscosity-reducing excipient compounds for protein formulations (2018-01-16),

5. 9605051 - Viscosity-reducing excipient compounds for protein formulations (2017-03-28),

Company Overview

Reform Biologics, LLC is a biotechnology company focused on developing innovative gene and cell therapies for rare genetic diseases. Our team of experts combines cutting-edge research with state-of-the-art technology to bring life-changing treatments to patients in need. With a commitment to excellence and a passion for improving healthcare, we aim to make a meaningful impact in the field of biologics.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

5 Patents

#105 in Woburn, MA

#2,895 in Massachusetts

#51,669 in US

Woburn, MA, United States of America

Reform Biologics, LLC

Forward Citations = 51

6 inventors:

Robert P Mahoney (5 out of 58 patents)

Philip Wuthrich (5 out of 15 patents)

David S Soane (5 out of 85 patents)

4. Mark Moody (3 out of 9 patents)

5. Daniel G Greene (3 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Reform Biologics, LLC. Retrieved from https://idiyas.com/company/reform-biologics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

13 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]